Could bogus scientific results be considered false advertising?

Could a scientific paper ever be considered an advertisement?

That was the question posed to a Tokyo court, in a criminal case where prosecutors argued — at the behest of Japan’s ministry of health — that a peer-reviewed paper containing faked data should be considered “fraudulent or exaggerated advertising” under that country’s laws.

In that case, however, the argument didn’t work. In March, the court decided that a fraudulent paper was not false advertising, allowing a pharmaceutical researcher at a Novartis subsidiary to escape jail time. The decision also cleared Novartis of charges and helped the company avoid a ¥4 million ($35,373 USD) fine.

According to an article in The Japan Times, the presiding judge Yasuo Tsujikawa said:

Continue reading Could bogus scientific results be considered false advertising?

Gender-based violence researcher now up to 10 retractions for plagiarism

A publisher has retracted all of the papers it published by a researcher in Nigeria, citing plagiarism.

The papers, all about terrorism and gender-based violence, were written by Oluwaseun Bamidele. The journal editors and the publisher, Taylor & Francis, decided to retract nine papers by Bamidele because of the overlap to other works — which he also failed to reference.

Bamidele — who also lost a paper on Boko Haram for the same reason — told us he didn’t learn about what constitutes plagiarism until his graduate studies, after he’d already written the now-retracted manuscripts:

Continue reading Gender-based violence researcher now up to 10 retractions for plagiarism

Journal retracts paper eight months after U.S. Feds announce findings of misconduct

In August, the U.S. Office of Research Integrity announced that a former postdoctoral fellow at the National Human Genome Research Institute (NHGRI) doctored data in two published papers.

It took one journal a little longer than five months to remove the researcher’s name from the co-author list, and replace one figure.

It took the second journal more than eight months to retract the paper.

Here’s the notice for “A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9,” published by the American Journal of Human Genetics (AJHG):

Continue reading Journal retracts paper eight months after U.S. Feds announce findings of misconduct

First author objects to retraction (his fourth) in chemistry journal

The first author of a 2013 chemistry paper is objecting to his co-authors’ decision to retract the paper, which contains duplicated figures.

We recently encountered a similar scenario with papers by first author Khalid Mahmood. In late 2015, Mahmood lost three papers in the journal ACS Applied Materials & Interfaces over duplicated images. One of the notices also indicated that the figures had “been published elsewhere and identified with different samples” — the same language used in the notice of the most recent retraction, in Journal of Materials Chemistry C.

Mahmood performed the work on the papers at Korea Advanced Institute of Science and Technology (KAIST), along with his two co-authors, Seung Bin Park and Hyung Jin Sung (also co-authors on two of the retracted papers in ACS Applied Materials & Interfaces).

Seung Bin Park, who is dean of the College of Engineering at KAIST, told us: Continue reading First author objects to retraction (his fourth) in chemistry journal

Journal: Here’s why we didn’t retract this duplicated paper

Here’s something we don’t see every day: A journal explains in an erratum notice why it chose not to retract a paper that contains data published elsewhere.

According to the Journal of Business and Psychology, the authors violated the journal’s transparency policy by failing to disclose that they’d used the same data in their 2014 in three others. However, the editors ultimately concluded the current paper was different enough from the other three to save it from being retracted.

Here’s the erratum: Continue reading Journal: Here’s why we didn’t retract this duplicated paper

Controversial researcher loses 12th paper that’s “literally copied;” authors object

A physics journal has retracted a 2011 paper by a group of scientists based in Italy, noting it’s “literally copied” from a paper by the same authors.

This is the 12th retraction for the paper’s first author Alberto Carpinteri, who is known in the engineering community for championing some controversial ideas, such as that the Shroud of Turin is as old as Jesus (contradicting carbon dating). In 2015, a journal he used to edit — Meccanica — retracted 11 of his papers, noting that “the editorial process had been compromised.”

In the latest notice, the Journal of Statistical Mechanics: Theory and Experiment (JSTAT) says its investigation found a substantial portion of the paper—including the main analysis and conclusion—had been lifted from a paper published in another journal several months before.

Last author of the latest paper to be retracted, Amedeo Manuello Bertetto from Polytechnic University of Turin, told us the authors strongly opposed the journal’s decision:  Continue reading Controversial researcher loses 12th paper that’s “literally copied;” authors object

Weekend reads: Prison for sharing an article?; which country has most fake peer review retractions; counterfeit reagents

The week at Retraction Watch featured a look at a school where everyone has published in possibly predatory journals, and doubts about a study of doing math unconsciously. Here’s what was happening elsewhere: Continue reading Weekend reads: Prison for sharing an article?; which country has most fake peer review retractions; counterfeit reagents

Publisher responds to public health journal editorial board’s “grave concerns”

A representative of Taylor & Francis has responded to concerns raised by former and current editorial board members of an occupational health journal, after the publisher took some significant actions without consulting the board.

The board’s main concerns: That the publisher hired a new editor with industry ties, and withdrew a paper by the former editor that was critical of corporate-sponsored research.

In a letter to the editorial board of the International Journal of Occupational and Environmental Health dated last week, managing director Ian Bannerman writes:

Continue reading Publisher responds to public health journal editorial board’s “grave concerns”

Top physicist loses another paper; tally now up to 7

A physics journal has retracted a paper from a leading physicist in India over duplication.

The paper’s first and corresponding Naba K. Sahoo has had six papers retracted for the same reason — four earlier this year and two last year.

The new retraction brings Sahoo’s total to seven, by our count.

The duplication allegations began several years ago, after Sahoo’s colleagues at Bhabha Atomic Research Centre (BARC), part of Indian government’s Department of Atomic Energy, accused him of plagiarizing his own work.

Thomas Lippert, editor-in chief of Applied Physics A: Material Science & Processing, told us: Continue reading Top physicist loses another paper; tally now up to 7

“Dramatic impact:” Authors misread breast cancer treatment database, retract paper

A journal has retracted a 2016 study on the use of radiation by breast cancer patients after the authors misinterpreted what was reported in a national cancer database.

Correcting for the error, according to the retraction notice, had a “dramatic impact on the original article data and conclusions.”

Quyen Chu, a surgeon at Louisiana State University Health Shreveport, told us that the problem appears to stem from a misunderstanding about the US National Cancer Database (NCDB). After the paper was published, the NCDB pointed out to Chu that a key data point had not been reliably or consistently collected during the timeframe relevant to the study. The database’s user’s manual says essentially the same thing; Chu said he and his authors read it, but misunderstood it.

The original Journal of the American College of Surgeons study looked at whether a 2004 National Comprehensive Cancer Network treatment guideline — which suggested some patients could avoid radiation on top of surgery and hormone therapy — led to an actual decrease in radiation therapy. But the error forced the authors to drop tens of thousands of patients treated before 2004, which had a severe impact on their ability to draw conclusions.

Chu told us:

Continue reading “Dramatic impact:” Authors misread breast cancer treatment database, retract paper